154 related articles for article (PubMed ID: 34659893)
1. CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer.
Liu W; Zhou Z; Li Y; Xu J; Shen Y; Luo S; Zhou Y; Wu X; Zhao H; Beer DG; He Y; Chen G
Am J Cancer Res; 2021; 11(9):4380-4393. PubMed ID: 34659893
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
3. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
[TBL] [Abstract][Full Text] [Related]
4. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
5. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
[TBL] [Abstract][Full Text] [Related]
6. CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
Zhang X; Zhang X; Mao T; Xu H; Cui J; Lin H; Wang L
J Cancer; 2021; 12(10):2797-2806. PubMed ID: 33854580
[TBL] [Abstract][Full Text] [Related]
7. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
8. CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity.
Li H; Wang L; Ruan Z; Li X; Yang Y; Fang J; Wang R
Expert Rev Clin Immunol; 2024 May; ():1-13. PubMed ID: 38752776
[TBL] [Abstract][Full Text] [Related]
9. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
[TBL] [Abstract][Full Text] [Related]
10. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
11. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
[TBL] [Abstract][Full Text] [Related]
14. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.
Zhu JH; Hong DF; Song YM; Sun LF; Wang ZF; Wang JW
Asian Pac J Cancer Prev; 2013; 14(2):1017-21. PubMed ID: 23621178
[TBL] [Abstract][Full Text] [Related]
16.
Yang X; Su W; Li Y; Zhou Z; Zhou Y; Shan H; Han X; Zhang M; Zhang Q; Bai Y; Guo C; Yang S; Beer DG; Chen G
Am J Transl Res; 2021; 13(3):1221-1232. PubMed ID: 33841651
[No Abstract] [Full Text] [Related]
17. Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway.
Lin HC; Li J; Cheng DD; Zhang X; Yu T; Zhao FY; Geng Q; Zhu MX; Kong HW; Li H; Yao M
Mol Ther Oncolytics; 2021 Jun; 21():23-36. PubMed ID: 33869740
[TBL] [Abstract][Full Text] [Related]
18. RAS-Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers.
Sumimoto H; Takano A; Teramoto K; Daigo Y
PLoS One; 2016; 11(11):e0166626. PubMed ID: 27846317
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of ABL1 upregulating the expression of PD-L1 and the therapeutic effect of PD-L1 and STAT3 inhibitors in lung adenocarcinoma.
Tang D; Jiang H; Li Z; Gao W; Sun Y
Neoplasma; 2021 May; 68(3):472-481. PubMed ID: 33147049
[TBL] [Abstract][Full Text] [Related]
20. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
